Pharmafile Logo

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

During the COVID-19 pandemic, multiple sclerosis (MS) experts were receiving many questions regarding the safety and efficacy of COVID-19 vaccination in patients receiving treatment for MS. The challenge was developing robust guidance in a timely manner with a goal of providing clarity on vaccine timing, efficacy, and safety, to support healthcare professionals and their patients.

An international Steering Committee of 10 MS experts came together to discuss, refine, and finalise 13 clinical recommendations. A further 28 MS experts from 19 countries also voted on the recommendations and helped to reach robust consensus through a virtual voting platform within a 90-day timeframe.

“Merck KGaA and Bedrock identified a beautifully simple solution to a pressing need. The judges recognised that achieving actional consensus on guidelines is always challenging, which is exacerbated by HCPs’ workloads, but the results achieved here are impressive. The approach was bold and imaginative, and the execution very well planned and delivered” PMEA Judging Panel 2022.

Stephen Marchant, MD of Bedrock said “We would like to add congratulations to Hashem Salloukh for partnering and trusting us with this critical project that provided a clear patient benefit. I would also like to thank my Bedrock team. This award is a testament to their freethinking, agility, and our belief that no two business challenges are the same.”

If you are looking for a team of freethinkers with bold and imaginative approaches to medical communications get in touch  freethinking@bedrock-health.com

This content was provided by Bedrock Healthcare Communications

Company Details

 Latest Content from  Bedrock Healthcare Communications 

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Thinking creatively about patient involvement in publications

Bedrock's freethinking spirit to reimagine publications is on course to include patients in the full end to end of the publication process.

Agility – The Bedrock Way

The rapid pace of innovation, regulatory systems and consumer behaviour requires real agility by medical communication professionals. Bedrock has the agility to keep up with the pace of change and...

Bedrock Healthcare Communications is proud to accept the PMEA for Agility in Pharma Market Excellence

Recognition for a bold and imaginative approach to an actionable clinical consensus for MS patients.

MIRANDA DINI APPOINTED CHIEF OPERATING OFFICER AT RESONANT GROUP

Two additional leadership moves also strengthen management team

The value medical communications bring to phase 2/3 of drug development

Bedrock’s Head of Strategy, Derek Annan, explains why the development of successful communication requires not only planning, strategy and execution (and measurement), it also needs to be able to respond...

Bedrock expands growing strategy and scientific teams

Award-winning Bedrock Healthcare Communications adds three new starters at an exciting time of growth. Meet our new faces and find out what drew them to Bedrock.

Bedrock Healthcare Communications appoints Louise Adamson as Head of Scientific Services

Louise Adamson joins Bedrock as Head of Scientific Services to drive scientific and strategic excellence and grow and develop the scientific team.

Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards

The award recognises outstanding achievement in flexing thinking and processes to ensure success.